相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Characterization of antibody drug conjugate positional isomers at cysteine residues by peptide mapping LC-MS analysis
Marie-Claire Janin-Bussat et al.
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES (2015)
Approaches to Interchain Cysteine-Linked ADC Characterization by Mass Spectrometry
John F. Valliere-Douglass et al.
MOLECULAR PHARMACEUTICS (2015)
Innovative Native MS Methodologies for Antibody Drug Conjugate Characterization: High Resolution Native MS and IM-MS for Average DAR and DAR Distribution Assessment
Francois Debaene et al.
ANALYTICAL CHEMISTRY (2014)
Dynamics of Intact Immunoglobulin G Explored by Drift-Tube Ion-Mobility Mass Spectrometry and Molecular Modeling
Kamila J. Pacholarz et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2014)
Statistical Modeling of the Drug Load Distribution on Trastuzumab Emtansine (Kadcyla), a Lysine-Linked Antibody Drug Conjugate
Michael T. Kim et al.
BIOCONJUGATE CHEMISTRY (2014)
Transglutaminase-Based Chemo-Enzymatic Conjugation Approach Yields Homogeneous Antibody-Drug Conjugates
Patrick Dennler et al.
BIOCONJUGATE CHEMISTRY (2014)
Chemoenzymatic Fc Glycosylation via Engineered Aldehyde Tags
Elizabeth L. Smith et al.
BIOCONJUGATE CHEMISTRY (2014)
Charge Reduction Stabilizes Intact Membrane Protein Complexes for Mass Spectrometry
Shahid Mehmood et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2014)
World Antibody-Drug Conjugate Summit, October 15-16, 2013, San Francisco, CA
Christine Klinguer-Hamour et al.
MABS (2014)
Site-specific antibody drug conjugates for cancer therapy
Siler Panowski et al.
MABS (2014)
Antibody-drug conjugate model fast characterization by LC-MS following IdeS proteolytic digestion
Elsa Wagner-Rousset et al.
MABS (2014)
Performing native mass spectrometry analysis on therapeutic antibodies
Natalie J. Thompson et al.
METHODS (2014)
Characterization of Therapeutic Antibodies and Related Products
Alain Beck et al.
ANALYTICAL CHEMISTRY (2013)
A Potent Anti-CD70 Antibody-Drug Conjugate Combining a Dimeric Pyrrolobenzodiazepine Drug with Site-Specific Conjugation Technology
Scott C. Jeffrey et al.
BIOCONJUGATE CHEMISTRY (2013)
Conjugation Site Heterogeneity Causes Variable Electrostatic Properties in Fc Conjugates
Nicholas J. Boylan et al.
BIOCONJUGATE CHEMISTRY (2013)
SGN-CD33A: a novel CD33-targeting antibody-drug conjugate using a pyrrolobenzodiazepine dimer is active in models of drug-resistant AML
May S. Kung Sutherland et al.
BLOOD (2013)
Review of Antibody-Drug Conjugates, Methods in Molecular Biology series
Alain Beck
mAbs (2013)
Antibody-drug conjugates
Stephen Ornes
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
PK assays for antibody-drug conjugates: case study with ado-trastuzumab emtansine
Randall Dere et al.
BIOANALYSIS (2013)
Charge-State Dependent Compaction and Dissociation of Protein Complexes: Insights from Ion Mobility and Molecular Dynamics
Zoe Hall et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2012)
The discovery and development of brentuximab vedotin for use in relapsed Hodgkin lymphoma and systemic anaplastic large cell lymphoma
Peter D. Senter et al.
NATURE BIOTECHNOLOGY (2012)
High-sensitivity Orbitrap mass analysis of intact macromolecular assemblies
Rebecca J. Rose et al.
NATURE METHODS (2012)
Synthesis of site-specific antibody-drug conjugates using unnatural amino acids
Jun Y. Axup et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
SAR3419: An Anti-CD19-Maytansinoid Immunoconjugate for the Treatment of B-Cell Malignancies
Veronique Blanc et al.
CLINICAL CANCER RESEARCH (2011)
Analytical methods for physicochemical characterization of antibody drug conjugates
Aditya Wakankar et al.
MABS (2011)
SG2285, a Novel C2-Aryl-Substituted Pyrrolobenzodiazepine Dimer Prodrug That Cross-links DNA and Exerts Highly Potent Antitumor Activity
John A. Hartley et al.
CANCER RESEARCH (2010)
Therapeutic potential of an anti-CD79b antibody-drug conjugate, anti-CD79b-vc-MMAE, for the treatment of non-Hodgkin lymphoma
David Dornan et al.
BLOOD (2009)
Targeted cancer therapy: Conferring specificity to cytotoxic drugs
Ravi V. J. Chari
ACCOUNTS OF CHEMICAL RESEARCH (2008)
Targeting HER2-Positive Breast Cancer with Trastuzumab-DM1, an Antibody-Cytotoxic Drug Conjugate
Gail D. Lewis Phillips et al.
CANCER RESEARCH (2008)
Site-specific conjugation of a cytotoxic drug to an antibody improves the therapeutic index
Jagath R. Junutula et al.
NATURE BIOTECHNOLOGY (2008)
Ion mobility-mass spectrometry analysis of large protein complexes
Brandon T. Ruotolo et al.
NATURE PROTOCOLS (2008)
Engineered antibody-drug conjugates with defined sites and stoichiometries of drug attachment
Charlotte F. McDonagh et al.
PROTEIN ENGINEERING DESIGN & SELECTION (2006)
Structural characterization of the maytansinoid -: monoclonal antibody immunoconjugate, huN901-DM1, by mass spectrometry
LT Wang et al.
PROTEIN SCIENCE (2005)
Mass spectral analyses of labile DOTA-NHS and heterogeneity determination of DOTA or DM1 conjugated anti-PSMA antibody for prostate cancer therapy
SX Lu et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2005)
Analysis of the composition of immunoconjugates using size-exclusion chromatography coupled to mass spectrometry
AC Lazar et al.
RAPID COMMUNICATIONS IN MASS SPECTROMETRY (2005)
SJG-136 (NSC 694501), a novel rationally designed DNA minor groove interstrand cross-linking agent with potent and broad spectrum antitumor activity.: Part 1:: Cellular pharmacology, in vitro and initial in vivo antitumor activity
JA Hartley et al.
CANCER RESEARCH (2004)
Development of potent monoclonal antibody auristatin conjugates for cancer therapy
SO Doronina et al.
NATURE BIOTECHNOLOGY (2003)
分享论文
